The safety and efficacy of paclitaxel and carboplatin with or without bevacizumab for treating patients with advanced nonsquamous non-small cell lung cancer with interstitial lung disease
Crossref DOI link: https://doi.org/10.1007/s00280-014-2590-x
Published Online: 2014-09-23
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shimizu, Ryoko
Fujimoto, Daichi
Kato, Ryoji
Otoshi, Takehiro
Kawamura, Takahisa
Tamai, Koji
Matsumoto, Takeshi
Nagata, Kazuma
Otsuka, Kyoko
Nakagawa, Atsushi
Otsuka, Kojiro
Katakami, Nobuyuki
Tomii, Keisuke
Text and Data Mining valid from 2014-09-23